Every material Form 8-K IDEX filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
IDEX Corporation appointed Sean M. Gillen, currently CFO of AAR CORP., as Senior Vice President and Chief Financial Officer effective January 5, 2026, replacing interim CFO Akhil Mahendra, who returns to his prior role as Vice President, Corporate Development. The company also said Senior Vice President and Chief Human Resources Officer Melissa S. Flores will resign effective December 19, 2025, and that it plans to fill that role externally.
Sean M. Gillen starts as CFO on January 5, 2026; he served as CFO of AAR CORP. from January 2019.
Offer terms include a $625,000 base salary, an 85% target incentive, a $3,000,000 new hire restricted stock award and a $325,000 sign-on bonus.
Melissa S. Flores, a named executive officer, departs effective December 19, 2025, to pursue another employment opportunity.
Akhil Mahendra had served as interim CFO since May 2025.
IDEX reported third-quarter 2025 results, with net sales up 10% on a reported basis to $878.7 million and GAAP diluted EPS up 8% to $1.70. The company narrowed its full-year 2025 GAAP diluted EPS outlook to $6.35 to $6.40 and raised its share repurchase authorization to $1 billion, which matters to shareholders because it signals continued capital returns alongside growth.
Q3 2025 net sales of $878.7 million rose 10% reported and 5% organically, helped by the Mott acquisition.
GAAP diluted EPS was $1.70 and adjusted diluted EPS was $2.03, up 8% and 7% respectively.
Full-year 2025 adjusted diluted EPS narrowed to $7.86 to $7.91, within prior guidance; organic sales growth of about 1% was unchanged.
The company repurchased $75 million of shares in Q3 2025 and $175 million year-to-date, and increased its authorization to $1 billion.
IDEX reported second quarter 2025 net sales of $865.4 million, up 7% from a year earlier and 1% organically, while GAAP diluted EPS fell to $1.74 from $1.86. The company lowered its full-year 2025 GAAP diluted EPS guidance to $6.30 to $6.44 from $6.56 to $6.95, citing customers taking a more cautious stance on larger orders, which matters to shareholders because it reduces expected full-year earnings.
Q2 net sales were $865.4 million, up 7% reported and 1% organic; Mott acquisition drove most of the increase.
GAAP diluted EPS was $1.74 versus $1.86; adjusted diluted EPS was $2.07 versus $2.06.
Full-year 2025 adjusted diluted EPS guidance was lowered to $7.85 to $7.95 from $8.10 to $8.45.
Third quarter 2025 GAAP diluted EPS is expected at $1.54 to $1.61, based on 2% to 3% organic sales growth.
IDEX CFO Abhishek Khandelwal will resign effective May 30, 2025, to pursue a new professional opportunity, and the company has retained a search firm for a permanent successor. Vice President of Corporate Development Akhil Mahendra will serve as interim CFO from the same date. The filing says the departure does not stem from any disagreement with auditors or management on accounting or disclosure matters.
Khandelwal notified IDEX of his resignation on May 19, 2025, effective May 30, 2025
Akhil Mahendra, 44, appointed interim CFO on May 20, 2025, while continuing as Vice President, Corporate Development
Mahendra's interim pay includes a restricted stock award with a $500,000 grant date fair value, cliff vesting three years after grant
The filing states the departure involved no disagreement with auditors or management on accounting, disclosure, or internal controls
IDEX reported first-quarter 2025 net sales of $814.3 million, up 2% from a year earlier but down 1% organically, while GAAP diluted EPS fell to $1.26 from $1.60. The company kept its full-year 2025 organic sales and diluted EPS guidance ranges and added $20 million of cost containment to offset potential tariff-related volume pressure, which matters to shareholders because profit fell even as reported sales grew.
Net sales were $814.3 million, up 2% reported and down 1% organically; the Mott acquisition drove the reported increase.
GAAP diluted EPS was $1.26 versus $1.60; adjusted diluted EPS was $1.75 versus $1.88.
Orders were a record $871.9 million, up 6% reported and 1% organically.
Full-year 2025 GAAP diluted EPS guidance is $6.56 to $6.95, unchanged; second-quarter guidance is $1.60 to $1.72.
IDEX Corporation appointed Stephanie Disher and Matthijs Glastra to its Board of Directors, effective February 21, 2025, expanding the Board from 10 to 12 directors. Directors David C. Parry and Livingston L. Satterthwaite will retire after the 2025 Annual Meeting of Stockholders and will not stand for re-election, reducing the Board to 10 seats at that point.
Stephanie Disher joins the Board effective February 21, 2025 and will serve on the Nominating and Corporate Governance Committee.
Matthijs Glastra joins the Board effective February 21, 2025 and will serve on the Audit Committee.
David C. Parry and Livingston L. Satterthwaite will retire following the 2025 Annual Meeting of Stockholders.
Disher is CEO of Atmus Filtration Technologies and Glastra is Chair and CEO of Novanta Inc.
IDEX reported fourth-quarter 2024 net sales of $863 million, up 9%, and diluted EPS of $1.62, up 13%. For full year 2024, sales were flat at $3.3 billion and diluted EPS fell 15% to $6.64, and the company projected 2025 organic sales growth of 1% to 3% with GAAP diluted EPS of $6.56 to $6.96.
Q4 2024 net sales $863 million, up 9% overall and 3% organically; adjusted diluted EPS $2.04, up 11%
Full-year 2024 net sales $3.3 billion, flat overall and down 2% organically; diluted EPS $6.64, down 15%
2025 outlook: full-year GAAP diluted EPS $6.56 to $6.96; first-quarter 2025 organic sales projected to decline 3% to 4%
Full-year 2024 operating cash flow $668 million, down 7%; free cash flow $603 million, down 4%
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every IDEX filing is on SEC EDGAR ↗. 8-K briefs of other companies →